Axon is a high-moat public-safety platform compounding at 30%+, with AI, backlog, and international expansion supporting upside despite premium valuation, dilution, and near-term margin risks.
Overview
Axon Enterprise is the leading connected public-safety technology platform, integrating TASER devices, body and fleet cameras, Evidence.com cloud evidence management, real-time operations, 911 workflow tools, drones, and AI applications. Its principal advantage is not an individual product but a connected workflow from emergency call to response, evidence storage, automated report drafting, and prosecutor case preparation. **Revenue quality is unusually strong: approximately 95% of sales come from multi-year subscriptions**, while NRR reached 126% in Q2 2026. Q2 revenue was $904.39 million, up 35.3% year over year and 3.18% above consensus; this was the 10th consecutive quarter above 30% growth. ARR rose 39% to $1.6 billion, and future contracted bookings increased 41% to $15.1 billion. Management raised 2026 revenue-growth guidance to 32%–34% and maintained approximately 25.5% adjusted EBITDA margin guidance. Valuation is demanding at a $627.85 share price, ~$49.82 billion market capitalization, 254.47x TTM P/E, 77.9x forward P/E, and 15.7x sales. The near-term setup is constructive after a 14.3% post-earnings decline and 20.2% rebound, with AI, backlog, Dedrone, and international expansion as catalysts.